Tokman Alexander Y 4
4 · ENDRA Life Sciences Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2023-01-30+9,621→ 9,621 totalExercise: $4.02Exp: 2033-01-30→ Common Stock (9,621 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.